1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Drug Development

Drug Discovery & Development Sector: Latest Market Trends and Statistics

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
33 votes

More market segments:

Global Drug Discovery and Development Industry

The global drug discovery and development industry (part of the wider pharmaceutical industry) involves the discovery and design of drugs through laboratory testing to treat disease and infection. With costs running high and few drugs making it to the market, drug discovery and development leaders are constantly seeking ways to reduce expenditure and boost efficiency.

One option companies frequently avail of is the practice of outsourcing sections of the discovery and development process. The global drug discovery outsourcing market is expected to grow from less than $7.5 billion in 2009 to a forecast worth of $18.5 billion in 2015, according to Business Insights. Meanwhile, the global drug discovery technologies market is expected to be worth more than $32 billion by 2012, growing at an annual compound rate in excess of 8%.

The industry requires heavy investment with no guarantee of results, including under 1% of discoveries going on to be approved by the US Food and Drug Administration. The process itself can take between 12 and 20 years, and cost over the $1.2 billion mark, reports the Alfred Mann Foundation for Biomedical Engineering.

Leading Market Segments

It is estimated that high throughput screening will be worth $12 billion by 2012, showing over 7% growth in the preceding five years.

Bioanalytical instruments have a forecast worth of $10.5 billion in 2012, demonstrating growth in excess of 9%. It is believed the segment of other technologies should come close to the $4.5 billion mark in 2012. Business Insights estimates the electronic data capture market for clinical trials will pass the $1 billion mark in 2016 at 13% annual growth.

Process: Drug Testing and Development

The steps involved in drug discovery begin with the identification of targets, which are genetic or cellular chemicals that influence disease. Once the target has been isolated, the compounds that may work best on them can in turn be determined. Next, the chosen target’s capacity to act on diseased cells is observed before compounds necessary to create a drug are determined, along with the drug target’s response to the compound. In the next phase compounds are compared and data is compiled to aid biopharmaceutical companies to determine the most promising compound for drug creation.

Once a drug has been designed, it enters the preclinical phase of development in which it is tested for up to five years to establish its impact on cells. The drug also undergoes toxicology testing to determine any possible harm to humans. In the clinical phase, drugs are administered to humans to test efficacy and potential side effects before companies seek authorization to market the new drug. Research compiled throughout the process is submitted to the relevant authority as the company awaits approval; this part of the process can last up to two years.

Contract Research Organization (CRO) Market Value (2005 - 2010) 

Read more »

You might be interested in these related markets:

Customer Support

Talk to Sam

+33 4 37 65 17 06

200 Reports
Product Initiative, Company, Demand
47 Statistics
Market Size, Company, Demand
680 Reports
Company Financials, Product Initiative, Company
57 Statistics
Company, Finance, Company Financials
8 Reports
Company Financials, Demand, Product Initiative
16 Statistics
Market Size, Finance, Company Financials
43 Reports
Market Size, Company, Company Financials
7 Statistics
Market Size, Finance, Company Financials
30 Reports
Company, Supply, Demand
19 Statistics
Finance, Company Financials, Company
16 Reports
Product Initiative, Market Size, Company Financials
3 Statistics
Company, Market Size, Finance
38 Reports
Company Financials, Company, Product Initiative
10 Statistics
Company, Finance, Company Financials
5 Reports
Company, Company Financials, Demand
7 Statistics
Company, Market Size, Finance
54 Reports
Company Financials, Demand, Company
42 Statistics
Finance, Company Financials, Company
8 Reports
Company, Company Financials, Demand
3 Statistics
Market Size, Finance, Company
Search in Drug Development Industry (About 800 reports)
Parent industry: Pharmaceutical
Related industries: Drug Delivery, Generic Drug, OTC, Prescription Drug, Therapy, Biopharmaceutical

About 6100 reports

Purchase Reports From Reputable Market Research Publishers

Respiratory Syncytial Virus (RSV): Forecast in Asia-Pacific Markets to 2028

Respiratory Syncytial Virus (RSV): Forecast in Asia-Pacific Markets to 2028

  • € 7889
  • Industry report
  • November 2019

Respiratory Syncytial Virus (RSV): Forecast in Asia-Pacific Markets to 2028SummaryHuman Respiratory Syncytial Virus (RSV) is an enveloped, single-stranded, negative-sense RNA orthopneumovirus belonging ...

Competing in the Global Therapeutic Drug Monitoring (TD ... € 7455 November 2019

The State of Personalized/ Precision Medicine € 7012 October 2019

Artificial Intelligence in Drug Discovery Market by Com ... € 4404 November 2019

ATP Assay Market by Product, Application, End User, Reg ... € 4404 October 2019

Cardiac Safety Services Market by Type, Services, End U ... € 4404 November 2019

Global Contract Research Organization (CRO) Market, For ... € 4341 November 2019

Analysis of the European Mass Spectrometry Market, 2018 € 4341 November 2019

Liquid Handling Technology Market to 2027 - Global Anal ... € 3990 November 2019

Global Electronic Trial Master File (eTMF) Systems Mark ... € 3683 November 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on